Cargando…

Use of convalescent serum reduces severity of COVID-19 in nonhuman primates

Passive transfer of convalescent plasma or serum is a time-honored strategy for treating infectious diseases. Human convalescent plasma containing antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently being used to treat patients with coronavirus disease 2019 w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cross, Robert W., Prasad, Abhishek N., Borisevich, Viktoriya, Woolsey, Courtney, Agans, Krystle N., Deer, Daniel J., Dobias, Natalie S., Geisbert, Joan B., Fenton, Karla A., Geisbert, Thomas W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901292/ https://www.ncbi.nlm.nih.gov/pubmed/33662255 http://dx.doi.org/10.1016/j.celrep.2021.108837

Ejemplares similares

A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease
por: Foster, Stephanie L., et al.
Publicado: (2022)

Natural history of nonhuman primates after conjunctival exposure to Ebola virus
por: Cross, Robert W., et al.
Publicado: (2023)

Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase
por: Cross, Robert W, et al.
Publicado: (2020)

Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase
por: Cross, Robert W., et al.
Publicado: (2020)

A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus
por: Cross, Robert W., et al.
Publicado: (2023)

Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates
por: Woolsey, Courtney, et al.
Publicado: (2018)

Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease
por: Cross, Robert W., et al.
Publicado: (2022)

Natural history of Sudan ebolavirus infection in rhesus and cynomolgus macaques
por: Woolsey, Courtney, et al.
Publicado: (2022)

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge
por: Woolsey, Courtney, et al.
Publicado: (2022)

Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus
por: Mire, Chad E., et al.
Publicado: (2016)

Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates
por: Mire, Chad E., et al.
Publicado: (2016)

Recombinant vesicular stomatitis virus–vectored vaccine induces long-lasting immunity against Nipah virus disease
por: Woolsey, Courtney, et al.
Publicado: (2023)

Crimean-Congo hemorrhagic fever virus strains Hoti and Afghanistan cause viremia and mild clinical disease in cynomolgus monkeys
por: Cross, Robert W., et al.
Publicado: (2020)

Bundibugyo ebolavirus Survival Is Associated with Early Activation of Adaptive Immunity and Reduced Myeloid-Derived Suppressor Cell Signaling
por: Woolsey, Courtney, et al.
Publicado: (2021)

Establishment of an African green monkey model for COVID-19
por: Woolsey, Courtney, et al.
Publicado: (2020)

Establishment of an African green monkey model for COVID-19 and protection against reinfection
por: Woolsey, Courtney, et al.
Publicado: (2020)

Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease
por: Mire, Chad E., et al.
Publicado: (2019)

Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody
por: Zeitlin, Larry, et al.
Publicado: (2021)

An Intranasal Exposure Model of Lethal Nipah Virus Infection in African Green Monkeys
por: Geisbert, Joan B, et al.
Publicado: (2020)

Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus
por: Mire, Chad E., et al.
Publicado: (2013)

Lipid nanoparticle siRNA treatment of Ebola virus Makona infected nonhuman primates
por: Thi, Emily P., et al.
Publicado: (2015)

Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy
por: Mire, Chad E., et al.
Publicado: (2016)

Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment
por: Cross, Robert W., et al.
Publicado: (2020)

Marburg and Ravn Viruses Fail to Cause Disease in the Domestic Ferret (Mustela putorius furo)
por: Cross, Robert W, et al.
Publicado: (2018)

Immune correlates of postexposure vaccine protection against Marburg virus
por: Woolsey, Courtney, et al.
Publicado: (2020)

A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus
por: Geisbert, Thomas W., et al.
Publicado: (2021)

Durability of a Vesicular Stomatitis Virus-Based Marburg Virus Vaccine in Nonhuman Primates
por: Mire, Chad E., et al.
Publicado: (2014)

Combination therapy protects macaques against advanced Marburg virus disease
por: Cross, Robert W., et al.
Publicado: (2021)

The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus
por: Cross, Robert W., et al.
Publicado: (2016)

Transcriptome Analysis of Circulating Immune Cell Subsets Highlight the Role of Monocytes in Zaire Ebola Virus Makona Pathogenesis
por: Menicucci, Andrea R., et al.
Publicado: (2017)

Author Correction: Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants
por: Versteeg, Krista, et al.
Publicado: (2019)

Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants
por: Versteeg, Krista, et al.
Publicado: (2017)

Comparative Transcriptomics in Ebola Makona-Infected Ferrets, Nonhuman Primates, and Humans
por: Cross, Robert W, et al.
Publicado: (2018)

Antagonism of STAT1 by Nipah virus P gene products modulates disease course but not lethal outcome in the ferret model
por: Satterfield, Benjamin A., et al.
Publicado: (2019)

A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection
por: Mire, Chad E, et al.
Publicado: (2020)

Single dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus
por: Mire, Chad E., et al.
Publicado: (2015)

Development of an Acute and Highly Pathogenic Nonhuman Primate Model of Nipah Virus Infection
por: Geisbert, Thomas W., et al.
Publicado: (2010)

Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical Trials
por: Cooper, Christopher L., et al.
Publicado: (2022)

Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease
por: Mire, Chad E, et al.
Publicado: (2013)

The immunomodulating V and W proteins of Nipah virus determine disease course
por: Satterfield, Benjamin A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tvccp1o6snh6ebie5dqsm0r55c